Projects per year
Personal profile
Research interests
Research Expertise:
Organic & Medicinal Chemistry | Organoboron Chemistry | Alternate Energy Materials
Medicinal Chemistry: We have been developing novel aza- and bora-heterocyclic compounds and betulin-based natural product derivatives as anti-cancer agents. In collaboration with Rowan School of Osteopathic Medicine, we have also identified few Withaferin-serotonin conjugates as potential therapeutic options for the treatment of Alzheimers’ Disease.
Value Added Chemicals from Biomass: Recent efforts in this area have included the development of new protocols for the effective conversion of biomass derived cellulosic materials into chemicals such as hydroxymethyl furfural and furan dicarboxylic acid for applications as bio-based polymers.
Honors and Awards:
Rowan University Wall of Fame Teaching Award, 2013, 2016
Eli Lilly International Graduate Scholar, 2000-2005, Purdue University
Member of:
American Chemical Society (www.acs.org)
Education/Academic qualification
Doctor of Philosophy, doctorate
Bachelor of Science, Bachelor, Pondicherry University
Master of Science, Master, University of Hyderabad
Fingerprint
Dive into the research topics where Subash Jonnalagadda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of Novel Therapeutic Agents for the Treatment of Triple Negative Breast Cancer
Jonnalagadda, S. (PI)
New Jersey Health Foundation, Inc. (NJHF)
2/15/24 → 2/14/25
Project: Other project
-
-
Collaborative Research: III: Medium: New Machine Learning Empowered Nanoinformatics System for Advancing Nanomaterial Design
Jonnalagadda, S. (PI)
2/1/24 → 1/31/25
Project: Other project
-
Automatic chemical toxicity assessment portal
Jonnalagadda, S. (PI)
9/29/23 → 12/31/24
Project: Other project
-
MNF as a dual-targeted therapy for pancreatic cancer
Jonnalagadda, S. (PI)
4/1/23 → 3/30/24
Project: Other project
-
Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients
Al-Odat, O. S., Nelson, E., Budak-Alpdogan, T., Jonnalagadda, S. C., Desai, D. & Pandey, M. K., Jul 2024, In: Cancers. 16, 13, 2381.Research output: Contribution to journal › Review article › peer-review
Open Access -
Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells
Bhowmick, K., von Suskil, M., Al-Odat, O. S., Elbezanti, W. O., Jonnalagadda, S. C., Budak-Alpdogan, T. & Pandey, M., Jun 30 2024, In: Heliyon. 10, 12, e33091.Research output: Contribution to journal › Review article › peer-review
Open Access -
Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma
Al-Odat, O. S., Guirguis, D. A., Schmalbach, N. K., Yao, G., Budak-Alpdogan, T., Jonnalagadda, S. C. & Pandey, M. K., Jan 2023, In: International Journal of Molecular Sciences. 24, 1, 644.Research output: Contribution to journal › Review article › peer-review
Open Access11 Scopus citations -
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment
Elbezanti, W. O., Challagundla, K. B., Jonnalagadda, S. C., Budak-Alpdogan, T. & Pandey, M. K., Mar 2023, In: Pharmaceuticals. 16, 3, 415.Research output: Contribution to journal › Review article › peer-review
Open Access9 Scopus citations -
Cancer on fire: role of inflammation in prevention and treatment
Pandey, M. K., Von Suskil, M., Chitren, R., Al-Odat, O., Jonnalagadda, S. C. & Aggarwal, B. B., Jan 1 2022, Current Advances for Development of Functional Foods Modulating Inflammation and Oxidative Stress. Elsevier, p. 605-626 22 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
4 Scopus citations